Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.

J Pediatr Orthop · 1998 · Classic · cited 269 times

Ian S. Corry, Aidan Cosgrove, C.M. Duffy, S. Alan McNeill, T C Taylor, H. Kerr Graham

Pediatric Orthopaedics

SUMMARY — THE REDUCTIONIn a randomized trial of 20 children with spastic equinus, botulinum toxin A matched serial casting in efficacy, with longer-lasting passive dorsiflexion gains, better gait maintenance at 12 weeks, and fewer side effects.
Abstract, as published

Conservative therapies for equinus in cerebral palsy may help to postpone calf surgery in younger children. This study reports a prospective randomised trial of intramuscular botulinum toxin A (BtA) as an alternative to serial casting in 20 children with a dynamic component to calf equinus. Outcome was assessed in the short term to show the effect of one treatment cycle. Assessments were by clinical examination, video gait analysis, and three-dimensional gait analysis. BtA was of efficacy similar to that of serial casting. Tone reduction in the BtA group allowed a more prolonged improvement in passive dorsiflexion, which may allow more opportunity for increase in muscle length. Gait analysis showed an improved mean ankle kinematic pattern in a subsection of both groups, which was maintained at 12 weeks in the BtA group, whereas the cast group relapsed. There were fewer side effects in the BtA group. Median time to reintervention was similar.

Featured in the 2026-10-19 issue.

← The Use of Endosteal Substitution in the Treatment of Recalci…

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.